Aspergillus fumigatus sterol 14-

demethylase (CYP51) isoenzymes
A (AF51A) and B (AF51B) were expressed in
Escherichia coli and
purified. The dithionite-reduced CO-P450 complex for AF51A was
unstable, rapidly denaturing to inactive P420, in marked contrast
to AF51B, where the CO-P450 complex was stable. Type I substrate
binding spectra were obtained with purified AF51B using lanosterol
(
Ks, 8.6 µM) and eburicol (
Ks, 22.6 µM). Membrane
suspensions of AF51A bound to both lanosterol (
Ks, 3.1 µM)
and eburicol (
Ks, 4.1 µM). The binding of azoles, with
the exception of fluconazole, to AF51B was tight, with the
Kd (dissociation constant) values for clotrimazole, itraconazole,
posaconazole, and voriconazole being 0.21, 0.06, 0.12, and 0.42
µM, respectively, in comparison with a
Kd value of 4 µM
for fluconazole. Characteristic type II azole binding spectra
were obtained with AF51B, whereas an additional trough and a
blue-shifted spectral peak were present in AF51A binding spectra
for all azoles except clotrimazole. This suggests two distinct
azole binding conformations within the heme prosthetic group
of AF51A. All five azoles bound relatively weakly to AF51A,
with
Kd values ranging from 1 µM for itraconazole to 11.9
µM for fluconazole. The azole binding properties of purified
AF51A and AF51B suggest an explanation for the intrinsic azole
(fluconazole) resistance observed in
Aspergillus fumigatus.
Antimicrobial Agents and Chemotherapy, October 2010, p. 4225-4234, Vol. 54, No. 10
0066-4804/10/$12.00+0 doi:10.1128/AAC.00316-10
No comments:
Post a Comment